Previous tubular perfusion studies show that there is an increased active urea transport activity in the initial inner medullary (IM) collecting duct in low-protein diet (LPD) and vitamin D (Vit D) animal models. To investigate the possible mechanisms that cause the urinary concentrating defect and to clone the new active urea transporter, we employed a modified two-tester suppression subtractive hybridization (ttSSH) approach and examined gene expression induced by LPD and Vit D in kidney IM base. Approximately 600 clones from the subtracted library were randomly selected; 150 clones were further confirmed to be the true positive genes by slot blot hybridization with subtracted probes from LPD and Vit D and sent for DNA sequencing. We identified 10 channel/transporter genes that were upregulated in IM base in LPD and Vit D animal models; 8 were confirmed by real-time PCR. These genes include aquaporin 2 (AQP2), two-pore calcium channel protein 2, brain-specific organic cation transporter, Na ϩ -and H ϩ -coupled glutamine transporter, and solute carrier family 25. Nine genes are totally new, and twelve are uncharacterized hypothetical proteins. Among them, four genes were shown to be new transmembrane proteins as judged by Kyte-Doolittle hydrophobic plot analysis. ttSSH provides a useful method to identify new genes from two conditioned populations. urine concentration; inner medulla LOW-PROTEIN DIET (LPD) decreases urine concentrating ability and the fractional excretion of urea (12, 14, 33) . In rats fed LPD, the maximal urine osmolality is reduced by 27-48% (15, 33). In kidney, urea reabsorption acts to build the osmolarity in the inner medulla (IM) and to reduce water loss under different physiological conditions. The aquaporin (AQP)2 water channel and urea transporter UT-A1 are the two major transporter proteins in the inner medullary collecting duct (IMCD). Both of their activities are regulated by vasopressin (also called antidiuretic hormone, ADH) in vivo, and their contributions to the urinary concentrating mechanism are well established. It has been reported that water (33) and urea (3, (12) (13) (14) reabsorption in the rat IMCD were changed when rats were fed with a low (8%)-protein diet. These changes could in part contribute to the urinary concentrating defect.
Hypercalcemia causes polyuria and impairs urine concentrating ability in humans and experimental animals (15, 20) . After administration of vitamin D (Vit D) for 24 h rats become hypercalcemic, and within 24 -48 h they exhibit polydypsia and polyuria (31) . It has been shown that Vit D-treated rats experience significant reductions in NaCl transport in the thick ascending limb (TAL) and a significant reduction of urine osmolality (29) .
Tubule perfusion studies have shown that LPD (12, 14) and hypercalcemia (15) induce active urea transporter expression in the initial IMCD. The kinetic properties of the active urea transporter are different from those of the current well-studied facilitated urea transporters UT-A and UT-B. The active transporter is Na ϩ dependent, ouabain sensitive, but phloretin insensitive (15, 32) . Although it has been proposed for over 40 years (16, 19) , the active urea transporter has not been cloned to date.
When a gene is upregulated under one condition but not another, subtractive hybridization (22) can be used to clone the differentially regulated gene. The population that contains differentially expressed genes is called the "tester," and the reference mRNA population is called the "driver." In 1996, Diatchenko et al. (9) introduced a new and highly effective subtractive hybridization, named suppression subtractive hybridization (SSH). This is a PCR-based method for selectively amplifying differentially expressed sequences. The tester cDNA is ligated to a special adaptor. After the secondary hybridization, PCR is performed by using the partial sequence of the adaptor as nested primers and is only carried out in those differentially expressed genes that contain the special adaptor. In the end, SSH selectively amplifies target cDNA fragments (differentially expressed) and simultaneously suppresses nontarget DNA amplification.
In this study, we introduced two testers for SSH that enabled us to identify the genes upregulated in both selected conditions. The genes from LPD-fed rats were ligated to adaptor 1 as tester 1, while other genes from Vit D-fed rats were ligated to adaptor 2 as tester 2. The genes were then subtracted by a nonconditioned control population (driver). After the suppression PCR, the final selected genes were those that were increased in both conditioned populations.
The purpose of the present study was to use two-tester SSH (ttSSH) to screen the upregulated genes induced by both LPD and Vit D conditions in the initial IM. We expected to identify three kinds of genes that may contribute to the impaired urinary concentration ability in response to protein restriction and hypercalcemia: 1) transporter/channel genes, 2) relevant regu-lated genes, and 3) the new sodium-dependent active urea transporter. Determining how the expression of epithelial transporter genes is altered will provide new insight into the mechanisms that lead to impaired urinary concentration under protein restriction and Vit D-induced hypercalcemia.
MATERIALS AND METHODS

Animal Models
All animal protocols were approved by the Emory University Institutional Animal Care and Use Committee. Male Sprague-Dawley rats (Charles River Laboratories, Wilmington, MA), 3 mo of age (ϳ150 g), were used and randomly subdivided into three groups as described previously (15): 1) untreated (control, n ϭ 5) rats were fed with 18% standard protein diet; 2) LPD rats (n ϭ 5) were given 14% protein diet (low-protein diet) for 2 wk; and 3) hypercalcemic rats (n ϭ 5) were fed with 18% standard protein diet containing Vit D (dihydrotachysterol, 4.25 mg · kg Ϫ1 · day Ϫ1 ; Roxane Laboratories) for 4 days. Animals were allowed ad libitum access to food and water.
IM Tissue Isolation and Poly(A) RNA Preparation
The kidneys were harvested, and the IMs were dissected. The 25% of the IM closest to the outer medulla was identified as the initial IM (IM1) (Fig. 1 ) and used for this experiment (mRNA preparation). The tubules in this region include the IMCDs and the thin limbs of Henle's loop of deep nephrons (Fig. 1) . Because of the small size of the tissue, IM1 tissues from five rats were pooled. Poly(A) RNA was extracted with FastTrack 2.0 kit (Invitrogen).
cDNA Synthesis and RsaI Digestion
The PCR-Select cDNA Subtraction Kit (BD Biosciences) was used for our ttSSH experiments. Two micrograms of mRNA was used for the first-strand cDNA synthesis. Four microliters of RNA (2 g) and one microliter of 10 M cDNA synthesis primer were incubated at 70°C for 2 min and then on ice. To the mixture were added 2 l of 5ϫ first-strand buffer, 1 l of dNTP mix (10 mM each), and 1 l of avian myeloblastosis virus (AMV) reverse transcriptase for a total of 10 l. The mixture was incubated at 42°C for 1.5 h in an air incubator and then put on ice. For the second-strand cDNA synthesis, the previous tubes (containing 10 l) were mixed with 16 l of 5ϫ second-strand buffer, 16 l of dNTP mix (10 mM), 4 l of 20ϫ second-strand enzyme cocktail (BD Biosciences), and 48.4 l of sterile H 2O. After incubation at 16°C for 2 h, 1 l of T4 DNA polymerase was added to the reaction and then incubated at 16°C for another 30 min. The reaction was terminated by adding 4 l of 20ϫ EDTA-glycogen mix. After phenol-chloroform extraction and ethanol precipitation, the DNA pellet was dissolved in 50 l of H 2O.
The double-strand cDNAs were digested by RsaI at 37°C for 1.5 h. The reactions were terminated by adding 2.5 l of 20ϫ EDTAglycogen mix. The DNAs were extracted with phenol-chloroform, precipitated with ethanol, and dissolved in 5.5 l of H 2O. Supplemental Figure S1 shows the agarose gel analysis of cDNA synthesis and RsaI digestion. 1 
Tester and Driver Preparation
The RsaI-digested cDNAs from LPD were ligated to adaptor 1 as tester 1, and digested cDNAs from Vit D were ligated to adaptor 2 as tester 2 (Fig. 2) . The ligation reaction was set up as 1 l of RsaI-digested cDNA, 2 l of 5ϫ ligation buffer, 1 l of T4 DNA ligase, and 3 l of sterile H 2O. The final reaction volume was 10 l, and the reaction was incubated at 16°C overnight. The reaction was stopped by adding 1 l of EDTA-glycogen mix, and the sample was heated at 75°C for 10 min and then stored at Ϫ20°C. The ligation efficiency was analyzed by PCR (Supplemental Fig. S2 ).
Two-Step Subtractive Hybridization
An excess of driver (control) was added individually to the two testers. The first hybridization reaction was set up as 1.5 l of RsaI-digested driver cDNA, 1.5 l of tester 1 (LPD) or tester 2 (Vit D) cDNA, plus 1 l of 4ϫ hybridization buffer. The samples were heat denatured for 1.5 min and allowed to anneal at 68°C for 8 h.
After the first hybridization, the two samples (tester 1 and tester 2) were combined, and 1 l of fresh denatured driver (control) was added. The sample was allowed a second hybridization for an additional 10 h at 68°C. The reaction was stopped by addition of 200 l of dilution buffer and heating at 68°C for 7 min. The sample was stored at Ϫ20°C until further processing.
Suppression PCR Amplification and TA Vector Ligation
The hybridized samples were subjected to the first round of PCR using the two adaptors as primers. Aliquots containing 1 l of subtracted samples from secondary hybridization, 2.5 l of 10ϫ PCR buffer, 0.5 l of dNTP, 1 l of PCR primer 1, and 0.5 l of 50ϫ Advantage cDNA polymerase mix, and 19.5 l of sterile H 2O were incubated at 75°C for 5 min to fill missing strands of adaptors. The 1 The online version of this article contains supplemental material. PCR reaction was set up for 27 cycles with 94°C for 30 s, 66°C for 30 s, and 72°C for 1.5 min.
The secondary selective amplification using nested primers (3= end of the adaptors) was performed to further reduce background PCR products and enrich for differentially expressed sequences. One microliter of the first amplified product was then used for second PCR, with 2.5 l of 10ϫ PCR buffer, 1 l of nested PCR primer 1, 1 l of nested PCR primer 2, 0.5 l of dNTP, 0.5 l of 50ϫ Advantage cDNA polymerase mix, and 18.5 l of sterile H 2O. The PCR was run for 27 cycles (94°C for 30 s, 66°C for 30 s, and 72°C for 1.5 min). Two microliters of the secondary amplified cDNAs was directly inserted into a TA cloning vector (Invitrogen) and transformed into DH5␣ competent cells (Stratagene) to generate the selective libraries. Supplemental Figure S3 shows the results of a successful control subtraction with cDNA made from skeletal muscle poly(A) ϩ RNA by adding HaeIII-digested ⌽X174. After the second hybridization, the ⌽X174/HaeIII bands were detected in the subtracted skeletal muscle control cDNA.
Slot Blot Hybridization
We picked ϳ600 white colonies from selective libraries generated in the TA vector. Plasmid DNA was prepared by using the Qiagen Miniprep Kit.
Plasmid DNA (0.1 g) was denatured with 4 M NaOH for 15 min and then loaded onto Hybond-N ϩ nylon membrane (Amersham) with a 48-well slot blot apparatus. A total of 576 DNA samples were used to prepare twelve 48-slot membranes. The membranes were neutralized in buffer (0.5 M Tris-Cl pH 7.4, 1.5 M NaCl). Duplicate membranes were prepared with the same samples for hybridization with LPD subtracted cDNA probes or control subtracted probes.
Subtracted cDNA probes (ϳ90 ng) generated from suppression subtractive PCR were labeled with [␣-
32 P]dCTP (Random Primer Labeling Kit from Amersham). One of the duplicated membranes was hybridized with LPD/Vit D subtracted cDNA probes, while another was hybridized with control subtracted probes. The membranes were incubated in Rapid-Hyb hybridization buffer (Amersham) containing denatured cDNA probes at 65°C for 2 h and then washed with 2ϫ SSC-0.1% SDS twice for 5 min at room temperature and 0.1ϫ SSC-0.1% SDS twice for 20 min at 65°C. The membranes were exposed to X-ray film. The signal of each sample in the paired films was compared. NIH ImageJ software was used to quantify the band density. A total of 150 clones that had a stronger signal with LPD/Vit D probes were selected for DNA sequencing.
Data Analysis
The Basic Local Alignment Search Tool (BLAST) was used to compare each individual DNA sequence to those in the public databases. The unknown (most are computer-predicted sequences) and new genes were analyzed for hydrophobic properties with KyteDoolittle plots and were judged as membrane protein genes when they appeared to possess multiple transmembrane segments (TMs).
Real-Time Reverse Transcription-PCR
To further confirm the upregulated genes identified by ttSSH, we carried out real-time quantitative PCR to assess the 10 transporter/ channel genes (see Table 1 ) selected by ttSSH. Kidney IM was dissected from normal, LPD, and Vit D rats (n ϭ 3 for each group). Total RNA was isolated with TRIzol (Invitrogen). cDNA was prepared by reverse transcription (RT) from 5 g of total RNA with SuperScript reverse transcriptase (BD Bioscience). Gene-specific primers were designed with the Invitrogen Primer program and are listed in Supplemental Table S2 . The cDNAs were quantified by real-time PCR amplification using the Bio-Rad iCycler Real-Time Detection System with a three-step protocol (95°C for 3 min, followed by 40 cycles of 30 s at 95°C, 30 s at 55°C, and 30 s at 72°C). Fluorescence of the amplificates was detected with the iQTM SYBR Green Supermix (Bio-Rad). Data were analyzed by iCycler software 3.0 (Bio-Rad). The gene expression levels were standardized relative to GAPDH.
RESULTS AND DISCUSSION
In an attempt to understand the complex changes accounting for the reduced urinary concentration ability occurring in kidneys from LPD and hypercalcemic rats, we performed a modified suppression subtractive hybridization (ttSSH) to identify altered genes in these two conditions. We focused on the initial IM. The renal tubules passing through this region are the collecting duct and thin limbs of Henle's loop as shown in Fig. 1 . AQP2 and urea transporter UT-A1 are the two most abundant transporter proteins in the IMCD and play important roles in urinary concentration. Previous studies (14, 31, 33) have examined the roles of AQP2 and UT-A1 in these two models. However, it is not clear whether any other transporters or channels are involved in the impaired urinary concentrating ability under these two conditions. In the present study, our goal was to identify some other transporters or channels, particularly the novel active urea transporter, that could con- tribute to the reduced urinary concentrating ability. We used two well-established animal models for this study. Previous studies have shown that rats fed a LPD grow and maintain normal values of serum albumin, creatinine, potassium, and total protein (12, 14) . This indicates that the defective urinary concentrating ability is not attributed to malnutrition. Instead of an 8% protein diet, here we used a 14% LPD as reported in our previous publication (11) . We found no difference in the reduction in urine concentrating ability between rats fed 8% and 14% protein (Supplemental Table S1 ). This suggests that the two LPDs may be inducing similar changes in urea handling in the kidney, including similar changes in active urea transport.
We made a few significant changes to the original SSH method proposed by Diatchenko et al. (9) . We introduced two-tester SSH (ttSSH) to screen the upregulated genes in two conditions (LPD and Vit D rats). The improved SSH enables us to narrow down the potential genes and increase the efficacy as shown in Fig. 2A . The suppression subtracted genes were further confirmed by slot blot hybridization. Figure 3 shows a pair of typical membranes hybridized with LPD subtracted cDNA probes or control subtracted probes. As expected, most of the subtracted gene expression was upregulated when detected by LPD and Vit D subtractive probes. However, some genes, as circled in Fig. 3 , were downregulated in LPD and Vit D rats.
On the basis of slot blot hybridization, we selected 150 DNA samples for sequencing. These gene expressions were increased in initial IM in both LPD-and Vit D-fed rats. To further confirm the selected upregulated genes from ttSSH, we tested 10 transporter/channel genes (see Table 1 ) through real-time quantitative PCR. Before the real-time PCR was performed, all the primers for the 10 genes were evaluated by conventional PCR. The RT-PCR results are shown in Supplemental Fig. S4 . One gene (ATP binding cassette transporter A13) could not be detected. For unknown reasons, the potassium channel TWIK, which we identified by RT-PCR (Supplemental Fig. S4 ), could not be amplified by the subsequent real-time PCR. In Fig. 4 , we examined the expression of eight transporter/ channel genes upregulated by real-time PCR in LPD-and Vit D-fed rats.
BLAST search revealed that most of the genes have been reported in the GenBank database. However, there are nine novel genes that had not been reported (see Table 2 ). We have organized all of the genes into different categories in a series of tables (Tables 1-5 ). The functions of some genes in the urinary concentration mechanism are also discussed. Table 1 summarizes the transporter and channel genes from the initial IM upregulated in LPD and Vit D rats. These transporters/ channels may contribute to the significant reduction of urinary concentration or may be involved in the adaptation to these two conditions (LPD and Vit D diet).
Transporter and Channel Genes
AQP2 and UT-A1 distributed in the IMCD play important roles in urine concentration. Vasopressin enhances the reabsorption of water and urea from the epithelial cells of the collecting duct, and this action is mediated by increased levels of cAMP (4, 25, 41) . Among 150 sequenced clones, 3 were identified as the water channel AQP2. The increased AQP2 could be a compensatory mechanism for the kidney in response to decreased urinary concentration.
In the selected 150 clones, we could not identify the UT-A1 gene. UT-A1 is normally distributed in the terminal IMCD. Under some conditions, such as the streptozotocin (STZ)-induced diabetic rat model, UT-A1 expression in the initial IMCD is significantly increased (27) . Tubular perfusion studies indicate increased facilitated urea transport in the initial IMCD in LPD-fed rats (12, 15) . In rats fed a LPD (8% protein), Kishore et al. (17) found that the urea clearance was markedly decreased, but it did not accompany the quantity alteration of UT-A1 protein in the IMCD. This suggests that LPD-and Vit D-induced changes in urea absorption by UT-A1 are not through transcriptional mechanisms. Indeed, we have found a number of posttranscriptional modifications that regulate UT-A1 urea transport activity, such as protein glycosylation (7), phosphorylation (4), and ubiquitination (8) .
The potassium channel TWIK-1 is a member of the twopore-domain potassium channel family. In kidney, it is expressed in proximal tubule, thin and thick ascending limbs, distal convoluted tubules, and medullary collecting duct. The function of TWIK-1 is to mediate K ϩ fluxes into the lumen that contribute to the repolarization during Na ϩ reabsorption through the electrogenic Na ϩ -phosphate cotransporter NaPi-2a (23) . Mice lacking TWIK-1 demonstrate impaired regulation of phosphate transport in the proximal tubule and water transport in the medullary collecting duct (24) . Increased TWIK-1 expression could be associated with increased sodium and/or water reabsorption in LPD-and Vit D-fed rats. Two-pore calcium channel protein 2. Studies of Two-pore calcium channel protein 2 (TPC2) are very limited, and the function of this channel is not clear. Northern blot analysis shows that human TPC2 mRNA is expressed in most human tissues, with higher levels in the liver and kidneys (6) . The increased TPC2 in Vit D-fed rats could be an adaptive change permitting the kidney to dispose of excess calcium in hypercalcemia.
Brain-specific organic cation transporter 3. There are three subtypes of organic cation transporter (OCT). OCT1 is a liver-specific organic cation transporter (37); OCT2 is specifically expressed in the kidney, while OCT3 is the subtype most represented in the brain (38) . OCT3 mediates extraneuronal catecholamine uptake in brain (38) . It has not been reported in kidney. OCT2 is expressed in the basolateral membrane of the renal proximal tubular cells (37) and mediates uptake from the blood into the kidney during the renal excretion of organic cations (2, 37). In our study, for the first time, we identified OCT3 also expressed in the initial IM. The function of OCT3 in the kidney is unknown. The significance of an increase of OCT3 in LPD-and Vit D-induced urinary concentration defect needs to be investigated. Na ϩ -and H ϩ -coupled glutamine transporter. Glutamine is the most abundant amino acid in blood and is involved in Fig. 4 . Quantification of gene expression by real-time PCR. Total RNAs were isolated from IM (n ϭ 3/group) and were reverse-transcribed and subjected to quantitative PCR (qPCR) assays using the fluorescent dye SYBR Green. Data are means Ϯ SD of qPCR quantifications from 1 of 3 independent experiments with similar results. Statistical analysis of the data was performed by 1-way analysis of variance (ANOVA) followed by Tukey honestly significant difference (HSD) tests. Reduced threshold cycle (Ct) indicates an increase of gene expression. *P Ͻ 0.05; **P Ͻ 0.01; NS, no significance. (10) . Kidneys produce ammonium to buffer and excrete acids through metabolism of glutamine. In kidney, Na ϩ -and H ϩ -coupled glutamine transporter (SNAT3) localized in the basolateral membrane of late proximal tubule segments plays an important role in regulating acid-base homeostasis (5) . Microarray gene profiling showed that SNAT3 gene expression is upregulated in mouse kidney during metabolic acidosis (26) . Our identification of SNAT3 in the initial IM suggests that there is an enhanced glutamine transport activity in this segment. However, the significance of SNAT3 in LPD-and Vit D-fed rats is unknown.
Unknown Genes
The initial motivation of the study was to clone the active sodium-dependent urea transporter (active UT) gene. In 1993, using tubule microperfusion, we demonstrated (14) an active urea transport process present in the IMCD1 (initial IMCD) segment when a rat was fed a LPD for 3 wk. The functional properties of this urea transporter are 1) ouabain reversibly inhibits urea transport; 2) replacing sodium in the perfusate with N-methyl-D-glucamine (NMDG) reversibly inhibits urea transport; 3) vasopressin in the bath has no effect on urea transport; and 4) phloretin does not change urea transport. Thus this transporter activity is sodium dependent and therefore totally different from the facilitated urea transporter UT-A. Active urea transporter activity in rat IMCD1 was upregulated by LPD, hypercalcemia, and furosemide treatment (3, (12) (13) (14) (15) 32 ). An increased urea absorption by active UT in this region may reduce urea delivery to the deeper portions of the IM, where it is needed to increase interstitial urea content and urine concentrating ability.
On the basis of the previous tubular perfusion studies, we here designed a modified SSH to screen for new genes from two of these animal models. The active urea transport activity is increased in these two animal models. Table 2 lists 9 new genes and 12 uncharacterized protein genes. We analyzed these proteins' predicted hydrophobic properties with Kyte-Doolittle plots and judged them to be putative membrane protein genes when they appeared to possess multiple TMs. Figure 5 shows 4 promising active urea transporter candidate genes from 21 unknown genes. The bioactivity for these four genes is currently under investigation.
Metabolism Enzymes
We also discovered a number of metabolism enzyme genes that are upregulated in LPD-and Vit D-fed animals (Table 3) . These changes may represent the kidney's adaptive reaction to the LPD and hypercalcemia-induced urinary concentration defect. Aldolase A is a glycolytic enzyme involved in glycolysis, gluconeogenesis, and fructose metabolism. Three aldolase Values are expressed in arbitrary density units. isoenzymes have been identified: aldolase A, the classical muscle enzyme; aldolase B, expressed predominantly in liver; and aldolase C, expressed predominantly in brain (40) . Yañez et al. (40) reported that aldolase A in the kidney medulla is localized in the thin limb and collecting ducts. This is in agreement with our finding. Other metabolic enzymes participating in glycolysis include transketolase, fucosidase, and glyceraldehyde-3-phosphate dehydrogenase. The increased glycolysis pathway enzymes in the LPD-and Vit D-fed rats may provide ATP energy for increased transporter activity induced by lower urine osmolality. Meanwhile, many metabolic intermediates may serve as organic osmolytes compensating for the decrease in other osmolytes such as urea and inositol (28) . Peterson et al. (28) found that feeding rats with a LPD resulted in an increase in IM sorbitol.
Transcription Factors and Nuclear Proteins
Undoubtedly, in response to the stress, strict transcriptional regulation by transcription factors and nuclear proteins plays an important role in the control of particular target gene expression. These transcription proteins recognize specific DNA elements in the promoter regions of target genes and function as repressors or activators of transcription. It has been reported that kidney chloride channels CLC-K1 and CLC-K2 gene transcription is activated by myc-associated zinc finger protein MAZ and suppressed by Krüppel-like zinc finger factor KKLF (35, 36) . Table 4 lists the transcription factors and nuclear protein genes upregulated in LPD-and Vit D-fed rats. However, none of these has been previously described in kidney IM. It would be interesting to determine whether and how these transcriptional factors affect transporter and channel expression and therefore regulate kidney urinary concentration mechanism in response to LPD and Vit D-induced hypercalcemia. Table 5 shows the miscellaneous upregulated genes identified in the initial IM of LPD-and Vit D-fed rats. These genes include protein kinases (protein kinase c-raf, NIMA-related Values are expressed in arbitrary density units. Numbers in parentheses indicate clone numbers Ͼ1. kinase 7, creatine kinase), protein phosphatase (protein phosphatase 1), cytoskeleton (actin-related protein 2/3 complex, cortactin, calsyntenin-1), scaffold proteins (cadherin-associated protein, ApoA-I binding protein), Ras-related proteins (muscle RAS oncogene homolog, RAP2A, RAS p21 protein activator 4), protein ubiquitination and degradation protein (ubiquitin-like protein UBIN, protein OS-9), and cell membrane lipid raft protein (flotillin 1). In response to the stimuli, the cells start a series of mechanisms to adapt to the changes. These changed gene products may play different roles in the regulation of transporter/channel synthesis, assembly, maturation, trafficking, and protein degradation. OS-9 is a newly identified component of the ERAD pathway. OS-9 regulates TRPV4 biogenesis by holding and protecting its monomers from a premature polyubiquitination and proteasomal degradation (1, 39) . Cortactin is an actin-related protein 2/3 (Arp2/3) complex-activating and filamentous (F)-actin-binding protein (30) . Actin remodeling has been shown to be required for AQP2 translocation to apical plasma membrane (34) . Calsyntenin-1 interacts with the kinesin-1 motor and mediates transport of various membranous organelles along microtubules (18, 21) .
Miscellaneous
In summary, in this study we employed a modified suppression subtractive hybridization (ttSSH) to investigate the gene expression from kidney initial IM in two animal models of impaired urinary concentration. We have identified a number of unrecognized transporters and channels in the initial IM that, together with AQP2 and UT-A1, could be important for the urinary concentration mechanism. We have obtained four unknown membrane protein genes upregulated in both LPD-and Vit D-fed rats. Successfully cloning the new urea transporter will facilitate our understanding of the urinary concentrating mechanism and water homeostasis. In addition, the ttSSH employed in this study is of great value. Gene microarrays have been widely applied to study gene expression and allow researchers to monitor thousands of gene expression simultaneously. However, most cDNA microarrays are created by spotting small amounts of PCR products. No matter how large the microarray is, it is limited. In this article, we present an effective and easily performed method for selecting the upregulated genes from two conditions, particularly for identifying new genes.
